|
Volumn 22, Issue SUPPL.1, 1996, Pages 113-115
|
Palliative treatment for advanced gastrointestinal cancer: Is response a suitable end-point?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
CISPLATIN;
DOXORUBICIN;
ETOPOSIDE;
FLUOROURACIL;
FOLINIC ACID;
METHOTREXATE;
MITOMYCIN;
SPARFOSIC ACID;
ADVANCED CANCER;
ADVERSE DRUG REACTION;
ANALGESIA;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PAIN;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONFERENCE PAPER;
DIGESTIVE SYSTEM CANCER;
DRUG RESPONSE;
FATIGUE;
HUMAN;
PALLIATIVE THERAPY;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
QUALITY OF LIFE;
TREATMENT OUTCOME;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
FLUOROURACIL;
GASTROINTESTINAL NEOPLASMS;
HUMANS;
INTERFERON ALFA-2A;
LEUCOVORIN;
PALLIATIVE CARE;
|
EID: 0029949985
PISSN: 03057372
EISSN: None
Source Type: Journal
DOI: 10.1016/S0305-7372(96)90072-9 Document Type: Article |
Times cited : (1)
|
References (5)
|